DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Anti-diabetic are 10




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_1700Ebselen
Anti-diabetic
Meniere Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus
Zika virus
MR766
NA
Cell viability assay
No significant effect (0 %)
Investigational
27571349
DrugRepV_1717Epalrestat
Anti-diabetic
Diabetic neuropathy
Zika virus
MR766
NA
Cell viability assay
No significant effect (0 %)
Investigational
27571349
DrugRepV_1771Ebselen
Anti-diabetic
Meniere Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus
Zika virus
MR766
NA
Cell viability assay
No significant effect (0 %)
Investigational
27571349
DrugRepV_1788Epalrestat
Anti-diabetic
Diabetic neuropathy
Zika virus
MR766
NA
Cell viability assay
Decrease (82.1 %)
Investigational
27571349
DrugRepV_1842Ebselen
Anti-diabetic
Meniere Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus
Zika virus
MR766
NA
Cell viability assay
No significant effect
Investigational
27571349
DrugRepV_1859Epalrestat
Anti-diabetic
Diabetic neuropathy
Zika virus
MR766
NA
Cell viability assay
No significant effect
Investigational
27571349
DrugRepV_2162Epalrestat
Anti-diabetic
Diabetic neuropathy
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Decrease (54.8385744 %)
Investigational
27742486
DrugRepV_2894Bindarit
Anti-diabetic
Coronary Restenosis and Diabetic Nephropathy
Chikungunya virus
vAc-CHIKV 26S-Rhir-E
NA
Fusion index-Fluorescent Intensities
Increase (-8.7514692 %)
Investigational
27742486
DrugRepV_7556Ebselen
Anti-diabetic
Meniere Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus
SARS Coronavirus-2
NA
NA
Plaque reduction assay
Decrease (50 %)
Investigational
32438446
DrugRepV_7557Ebselen
Anti-diabetic
Meniere Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus
SARS Coronavirus-2
NA
NA
Plaque reduction assay
Decrease (90 %)
Investigational
32438446